文献速递临床试验与 GCP

机器人与开放部分胰十二指肠切除术对比:EUROPA随机对照预试验研究方案

Evaluation of robotic versus open partial pancreatoduodenectomy-study protocol for a randomised controlled pilot trial (EUROPA, DRKS00020407).
PubMed 文献 · Trials · 2021-01-08

EUROPA试验是首个对比机器人部分胰十二指肠切除术(RPD)与开放手术(OPD)的随机对照预试验,计划随机80例择期患者,主要终点为90天内综合并发症指数(CCI)评估的总体术后并发症发生率,旨在为未来多中心确证性试验提供设计依据。

要点

  • 首个RPD与OPD的随机对照预试验,计划随机80例、分析64例。
  • 主要终点为术后90天内总体并发症,采用综合并发症指数(CCI)评估。
  • 试验结果将用于设计未来多中心确证性疗效试验。

核心结论

  • EUROPA试验是首个比较RPD与OPD的随机对照试验,将评估术后并发症差异以设计未来多中心确证性疗效试验。

研究设计与样本

  • 随机对照、非盲、探索性外科试验,两组平行设计,计划随机80例择期部分胰十二指肠切除术患者。
  • 排除标准包括NCCN指南定义的临界可切除或不可切除胰头癌、远处转移及ASA评分>III。
  • 预计每组约8例术中脱落,最终需分析64例患者。
  • 试验注册号DRKS00020407,2020年3月9日注册。

关键数值与推荐

  • 主要终点为指数手术后90天内总体术后并发症,采用综合并发症指数(CCI)测量。
  • 次要终点包括招募可行性、临床、肿瘤学与安全性参数、生活质量及成本效果。

临床怎么用

  • 该预试验结果将为未来多中心确证性试验的设计提供依据,暂不直接改变临床实践。

局限性

  • 原文提及既往小样本非随机研究显示RPD围手术期结果令人鼓舞但偏倚风险较高,故需随机对照比较。
  • 试验为探索性预试验,样本量较小,预计每组约8例术中脱落。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Partial pancreatoduodenectomy (PD) is the indicated surgical procedure for a wide range of benign and malignant diseases of the pancreatic head and distal bile duct and offers the only potential cure for pancreatic head cancer. The current gold standard, open PD (OPD) performed via laparotomy, is associated with morbidity in around 40% of cases, even at specialised centres. Robotic PD (RPD) might offer a viable alternative to OPD and has been shown to be feasible. Encouraging perioperative results have been reported for RPD in a number of small, non-randomised studies. However, since those studies showed a considerable risk of bias, a thorough comparison of RPD with OPD is warranted. METHODS: The EUROPA (EvalUation of RObotic partial PAncreatoduodenectomy) trial is designed as a randomised controlled unblinded exploratory surgical trial with two parallel study groups. A total of 80 patients scheduled for elective PD will be randomised after giving written informed consent. Patients with borderline or non-resectable carcinoma of the pancreatic head as defined by the National Comprehensive Cancer Network guidelines, distant metastases or an American Society of Anaesthesiologists (ASA) score > III will be excluded. The experimental intervention, RPD, will be compared with the control intervention, OPD. An intraoperative dropout of approximately eight patients per group is expected because they may receive another type of surgical procedure than planned. Overall, 64 patients need to be analysed. The primary endpoint of the trial is overall postoperative morbidity within 90 days after index operation, measured using the Comprehensive Complication Index (CCI). The secondary endpoints include the feasibility of recruitment and assessment of clinical, oncological and safety parameters and quality of life and cost-effectiveness. DISCUSSION: The EUROPA trial is the first randomised controlled trial comparing RPD with OPD. Differences in postoperative morbidity will be evaluated to design a future multicentre confirmatory efficacy trial. TRIAL REGISTRATION: German Clinical Trial Register DRKS00020407 . Registered on 9 March 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Klotz R, Dörr-Harim C, Bruckner T, et al. Evaluation of robotic versus open partial pancreatoduodenectomy-study protocol for a randomised controlled pilot trial (EUROPA, DRKS00020407). Trials. 2021. PMID: 33419452. doi:10.1186/s13063-020-04933-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。